TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Has the Worst Passed for Valeant Pharmaceuticals Intl Inc.?

    After what can only be described as an epic collapse, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:NRX) may have turned the first…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is It Going to Default?

    While Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) received a default notice, I expect it to be just fine, and it might…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Cleans Shop. Is it a Buy Now?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is looking to turn around with operational changes. However, it's not a buy until it…

    Read more »

    The Motley Fool
    Energy Stocks

    Will These 3 Struggling Stocks Survive 2016?

    This year could be fatal for Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE), Sears Canada Inc. (TSX:SCC), and Valeant Pharmaceuticals Intl Inc.…

    Read more »

    The Motley Fool
    Investing

    Good News for Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) gets some good news on its CEO search.

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Still an Option?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been through considerable controversy over the past few months, raising concerns about whether or…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is a Buy if its Parts Sell

    Until Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) sells some of its business and pays down debt, investors should still avoid it.…

    Read more »

    The Motley Fool
    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc.?

    Is Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) a falling knife you should avoid, or should you buy it with the potential…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: This Hedge Fund Manager Says Buy

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is under fire, but hedge fund manager Bill Ackman says buy.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: What Michael Pearson’s Testimony Means for the Company

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares declined by more than 7% after Michael Pearson was subpoenaed by a Senate committee.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: What Exactly Is Going On Here?

    There was another suspicious press release from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Jim Chanos and the Original Short Thesis

    Jim Chanos was short Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) before the company ran into problems.

    Read more »